{"id":717,"date":"2021-04-21T08:15:27","date_gmt":"2021-04-21T08:15:27","guid":{"rendered":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/?p=717"},"modified":"2021-04-21T08:15:27","modified_gmt":"2021-04-21T08:15:27","slug":"nota-informativa-muh-fv-07-2021","status":"publish","type":"post","link":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/2021\/04\/21\/nota-informativa-muh-fv-07-2021\/","title":{"rendered":"Nota Informativa MUH (FV), 07\/2021"},"content":{"rendered":"<p><a href=\"https:\/\/www.aemps.gob.es\/informa\/notasinformativas\/medicamentosusohumano-3\/seguridad-1\/2021-seguridad-1\/vacuna-frente-a-la-covid-19-de-janssen-conclusiones-de-la-evaluacion-del-riesgo-de-trombosis-junto-con-trombocitopenia\/\">Vacuna frente a la COVID-19 de Janssen: conclusiones de la evaluaci\u00f3n del riesgo de trombosis junto con trombocitopenia<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vacuna frente a la COVID-19 de Janssen: conclusiones de la evaluaci\u00f3n del riesgo de trombosis junto con trombocitopenia<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-717","post","type-post","status-publish","format-standard","hentry","category-seguridad"],"_links":{"self":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/comments?post=717"}],"version-history":[{"count":1,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/717\/revisions"}],"predecessor-version":[{"id":718,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/717\/revisions\/718"}],"wp:attachment":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/media?parent=717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/categories?post=717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/tags?post=717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}